http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105169393-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105169393-B |
| titleOfInvention | Application in the anti-acute myeloid leukemias of miRNA-548a-3p |
| abstract | The present invention relates to applications of the miRNA 548a 3p in anti-acute myeloid leukemia.MiRNA 548a 3p can be used for whether diagnosis patient suffers from acute myeloid leukemia.The experiment proved that miRNA 548a 3p can efficiently differentiate the sample of acute myeloid leukemia sample and Healthy People.MiRNA 548a 3p can be also used for preparing the drug for the treatment of acute myeloid leukemia.The present invention substantially increases the sensibility and specificity of Diagnosing Acute Myeloid Leukemia, while the gene therapy for acute myeloid leukemia provides new target spot. |
| priorityDate | 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.